Global Osteoarthritis Drugs Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application

Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint, including analgesics, nonsteroidal anti-inflammatory drugs, corticosteroids, hyaluronic acid, and phase III drugs.

Market Analysis and Insights: Global Osteoarthritis Drugs Market
In 2020, the global Osteoarthritis Drugs market size was US$ 5477.4 million and it is expected to reach US$ 7675.4 million by the end of 2027, with a CAGR of 4.5% between 2021 and 2027
Global Osteoarthritis Drugs Scope and Market Size
The global Osteoarthritis Drugs market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Osteoarthritis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), byType, and by Application for the period 2016-2027.

Segment by Type
Oral
Injection
External

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Company
Johnson & Johnson
Pfizer
Eli Lilly
Abbott
GlaxoSmithKline
Sanofi
Flexion Therapeutics

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Colombia
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE